Evidence map›Paper›PMID 27612482›Full record

ArticleInternational ophthalmology2017

Removal of Tenon fortified by conjunctival-limbal autograft in treatment of pterygium.

Suleyman Ciftci, Eyup Dogan, Umut Dag, Leyla Ciftci

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Suleyman CiftciDepartment of Ophthalmology, Diyarbakır Training and Research Hospital, 21000, Diyarbakır, Turkey. ciftci1977@hotmail.com.
Eyup DoganDepartment of Ophthalmology, Diyarbakır Training and Research Hospital, 21000, Diyarbakır, Turkey.
Umut DagDepartment of Ophthalmology, Diyarbakır Training and Research Hospital, 21000, Diyarbakır, Turkey.
Leyla CiftciDepartment of Cardiology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey.
Education Training And Research · USDicle University · TRDiyarbakır Askeri Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe a simple and effective technique for the prevention of pterygium recurrence.

methodsThis is a retrospective consecutive single-center case series with recurrence rate as the main outcome measure. Dissection of the conjunctiva, the Tenon's layer, and the sclera was continued up to the insertion of medial rectus. The exposed Tenon's layer was excised for 2 to 3 mm. The entire free edges of the conjunctiva was tacked firmly to the sclera. The conjunctival-limbal graft was sutured firmly to the sclera, recipient limbus, and to the conjunctiva incorporating the reciprocal edges.

resultsWe report findings in a total of 36 patients, with 20 (%55.5) males and 16 (%44.4) females. Median age of the patients was 44.5 years (range 16-80). The mean follow-up period was 23.1 ± 6.5 months. The mean size of pterygium in mm length was 3.8 ± 0.7. Recurrence did not occur in any patient. Diplopia was not reported by any patients.

conclusionsConjunctival-limbal autograft combining with selective exicison of Tenon's layer but without damage to any essential tissue such as the semilunar fold or Tenon's capsule pulley is a relatively simple and effective procedure.

Indexed as

AdolescentAdultAgedAged, 80 and overAutograftsConjunctivaCorneal TransplantationFemaleFollow-Up StudiesHumansLimbus CorneaeMaleMiddle AgedOphthalmologic Surgical ProceduresPterygiumRecurrenceConjunctival-limbal autograftPterygiumRecurrenceTenon’s layer

Identifiers

PMID27612482
OpenAlexW2513282519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.